scPharmaceuticals Inc. (SCPH) Misses Q3 EPS by 45c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q3 EPS of ($0.75), $0.45 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $10.02 million versus the consensus estimate of $10.81 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 22nd Century Group files prospectus for warrant share resale
• Nutrien warns shareholders about below-market mini-tender offer